SAM
RIGL icon

Shell Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Shell Asset Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,643
Closed -$372K – 1485
2020
Q4 		$372K Buy
+10,643
New +$308K 0.01% 914

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Shell Asset Management's RIGL Position: Q1 2021 in Review

Shell Asset Management sold out of Rigel Pharmaceuticals (RIGL) in Q1 2021, closing a stake of 10,643 shares — an estimated $372K sold.

Shell Asset Management first reported a position in RIGL in Q4 2020 and held it in 1 quarter. The position peaked at $372K in Q4 2020. 152 funds tracked by Wall St. Rank hold RIGL as of Q1 2021.

  • Shell Asset Management reported no remaining Rigel Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Shell Asset Management sold 10,643 Rigel Pharmaceuticals shares in Q1 2021, an estimated $372K.
  • Shell Asset Management first reported a position in Rigel Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • Shell Asset Management's Rigel Pharmaceuticals position peaked at $372K in Q4 2020.
  • 152 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2021.

Based on Shell Asset Management's 13F filing for Q1 2021, filed 10 May 2021.